Finishing off fibrils

Research output: Contribution to journalComment/debatepeer-review

2 Scopus citations


Bortezomib shows high activity in light chain amyloidosis. Responses occur rapidly and are seen in cardiac, renal, and hepatic disease. Toxicity in this fragile population is significant.

Original languageEnglish (US)
Pages (from-to)1456-1457
Number of pages2
Issue number8
StatePublished - Nov 19 2009

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'Finishing off fibrils'. Together they form a unique fingerprint.

Cite this